Investing

RAD receives IND approval from US FDA for Betabart (RV-01)

by admin
RAD receives IND approval from US FDA for Betabart (RV-01)

Radiopharm Theranostics (RAD:AU) has announced RAD receives IND approval from US FDA for Betabart (RV-01)

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Stallion Uranium Announces Update to Previously Announced Technology...

August 1, 2025

Apex Announces Update on Financing

October 2, 2025

Nickel Price Update: Q3 2025 in Review

October 30, 2025

U.S. Investors Lead Oversubscribed $17m Placement

December 8, 2025

Josef Schachter: Oil/Gas Stock Buy Window — 3...

October 15, 2025

Hempalta Secures 90-Day FCC Forbearance Extension as Company...

July 5, 2025

Nick Hodge: Copper is My Top 2026 Pick,...

November 17, 2025

Transition Metals: Discovery-focused Multi-commodity Exploration Company

January 20, 2026

Altech – CERENERGY Project Secures German Grant Approval

January 6, 2026

Execution of Land Access Agreement

November 25, 2025